166 related articles for article (PubMed ID: 6280473)
1. Angiotensin-converting enzyme inhibition and prostaglandins.
Swartz SL; Williams GH
Am J Cardiol; 1982 Apr; 49(6):1405-9. PubMed ID: 6280473
[TBL] [Abstract][Full Text] [Related]
2. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.
Swartz SL; Williams GH; Hollenberg NK; Levine L; Dluhy RG; Moore TJ
J Clin Invest; 1980 Jun; 65(6):1257-64. PubMed ID: 6997332
[TBL] [Abstract][Full Text] [Related]
3. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
Zacharieva S; Koev D; Andonova K
Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
[TBL] [Abstract][Full Text] [Related]
4. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
[TBL] [Abstract][Full Text] [Related]
5. Increase in prostaglandins during converting enzyme inhibition.
Swartz SL; Williams GH; Hollenberg NK; Crantz FR; Levine L; Moore TJ; Dluhy RG
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():133s-135s. PubMed ID: 6256109
[TBL] [Abstract][Full Text] [Related]
6. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
7. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.
Moore TJ; Crantz FR; Hollenberg NK; Koletsky RJ; Leboff MS; Swartz SL; Levine L; Podolsky S; Dluhy RG; Williams GH
Hypertension; 1981; 3(2):168-73. PubMed ID: 6260645
[TBL] [Abstract][Full Text] [Related]
8. Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K
Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280
[TBL] [Abstract][Full Text] [Related]
9. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721
[TBL] [Abstract][Full Text] [Related]
10. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
Gainer JV; Morrow JD; Loveland A; King DJ; Brown NJ
N Engl J Med; 1998 Oct; 339(18):1285-92. PubMed ID: 9791144
[TBL] [Abstract][Full Text] [Related]
11. Effect of indomethacin on antihypertensive action of captopril in hypertensive patients.
Fujita T; Yamashita N; Yamashita K
Clin Exp Hypertens (1978); 1981; 3(5):939-52. PubMed ID: 7026199
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenous angiotensin II and prostaglandins in the antihypertensive mechanism of angiotensin converting enzyme inhibitor in hypertension.
Omata K; Abe K; Tsunoda K; Yasujima M; Chiba S; Sato M; Kudo K; Yoshinaga K
Clin Exp Hypertens A; 1987; 9(2-3):569-74. PubMed ID: 3038419
[TBL] [Abstract][Full Text] [Related]
13. Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter's syndrome.
Fujita T; Ando K; Sato Y; Yamashita K; Nomura M; Fukui T
Am J Med; 1982 Jul; 73(1):71-6. PubMed ID: 7046439
[TBL] [Abstract][Full Text] [Related]
14. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
Dzau VJ; Swartz SL
Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
[TBL] [Abstract][Full Text] [Related]
17. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
[TBL] [Abstract][Full Text] [Related]
18. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
20. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
